The authors evaluated the effect of chronic administration of the drug on brain interstitial fluid Aβ and Aβ plaque size in the amyloid precursor protein (APP)/presenilin 1 mouse model of AD (APP/PS1+/− hemizygous mice to wild-type C3H/B6 mice). The gene discussed is APP; the disease is Alzheimer disease.